News
1h
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
StockStory.org on MSN8h
Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst QuestionsHims & Hers Health delivered a first quarter that surpassed Wall Street’s expectations, driven by strong adoption of its ...
4d
Live Science on MSNDrug slashes migraine days by half in early trial — and it may work with completely 'new mechanism'The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...
A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...
A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...
GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results